There is still a lot of crucial research that must be undertaken, but there has been great progress regarding further understanding the links between metabolic peptides like GLP-1, GIP, and PP, as well as their agonists and properties, in order to combat obesity and neuroinflammation. This evidence concerns the gene GLP1R and obesity disorder.